Print version
Search Pub Med
CYP2J34 is expressed, but not regulated by toll-like receptor (TLR) ligands in porcine peripheral blood mononuclear and vascular smooth muscle cells. Epoxygenases are specific CYP450 enzymes that convert fatty acids into epoxy-oxylipins e.g. arachidonic acid in to epoxy-eicosatrienoic acids (EETs) (1). Epoxygenase products are considered protective in cardiovascular disease. We and others have shown a role for CYP2J2 in vascular and inflammatory cells. However, CYP450 in particular show a great deal of species variability. Pigs are a commonly used large animal model to study cardiovascular disease. We have therefore examined the expression and regulation of CYP2J34 (the homologue of CYP2J2) in porcine vascular smooth muscle cells and peripheral blood mononuclear cells (PBMCs). Vascular smooth muscle from carotid vessels (pCASMC) were grown by explant (2). Porcine blood was collected by venupuncture and collected in to citrate. Human leukocyte cones were obtained from the NHS Blood Bank. pPBMCs were isolated by density centrifugation and cultured in RPMI media supplemented with FCS (10%) and antibiotics (1%). pCASMC, or pPBMCs (passage 2-3) were either left unstimulated or stimulated with the TLR4 agonist LPS (10ng/ml) or a panel or TL ligands for 4h, and mRNA levels for CYP2J34, TNFα and the housekeeping gene β-actin measured by qRT-PCR.
Here we show for the first time that pCASMC and pPBMC contain the epoxygenase CYP2J34, the porcine homologue of human CYP2J2. Unlike CYP2J2, CYP2J34 does not appear to be induced by LPS (TLR-4) or other TLR ligands. 1. Bishop-Bailey D et al., (2014) Annu Rev Nutr. 34: 261-79. 2. Bishop-Bailey D et al., (1998) Arterioscler Thromb Vasc Biol. 18:1655-61.
|